FDA Label for Novavax Covid-19 Vaccine, Adjuvanted

View Indications, Usage & Precautions

Novavax Covid-19 Vaccine, Adjuvanted Product Label

The following document was submitted to the FDA by the labeler of this product Novavax, Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Package/Label Display Panel – Vial Label



NDC 80631-100-01

NOVAVAX

COVID-19 Vaccine,

Adjuvanted

Suspension for intramuscular injection
Multi-dose vial (10 doses of 0.5 mL)

Record date/time of first use:

Date:       Time:

Manufactured for:
Novavax, Inc., Gaithersburg, MD 20878


Package/Label Display Panel – Vial Carton



NDC 80631-100-10

10 Multi-Dose Vials

(each vial contains 10 doses of 0.5 mL)

NOVAVAX

COVID-19 Vaccine, Adjuvanted

suspension for
intramuscular injection

For use under Emergency Use Authorization

NOVAVAX


* Please review the disclaimer below.